To determine the clinical significance of the seven hub GRGs identified in GC, the expression levels of STC1, CLDN9, EFNA3, ZBTB7A, NT5E, NUP50, and CXCR4 were compared between normal gastric tissues and GC tissues using the Oncomine database (Figure 10). This evidence concerns the gene CLDN9 and gastric cancer.